Federated Hermes’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$74.4M Hold
14,666,600
0.14% 181
2025
Q1
$44.3M Hold
14,666,600
0.1% 255
2024
Q4
$53.1M Hold
14,666,600
0.12% 226
2024
Q3
$25.8M Hold
14,666,600
0.06% 369
2024
Q2
$22.9M Buy
14,666,600
+4,497,000
+44% +$7.02M 0.05% 376
2024
Q1
$19.8M Hold
10,169,600
0.05% 417
2023
Q4
$14.3M Hold
10,169,600
0.04% 469
2023
Q3
$16.1M Sell
10,169,600
-20,366
-0.2% -$32.2K 0.04% 417
2023
Q2
$22M Hold
10,189,966
0.05% 355
2023
Q1
$21.4M Buy
10,189,966
+4,958,366
+95% +$10.4M 0.05% 374
2022
Q4
$11.5M Buy
5,231,600
+9,350
+0.2% +$20.5K 0.03% 506
2022
Q3
$15.7M Hold
5,222,250
0.05% 434
2022
Q2
$14.8M Hold
5,222,250
0.04% 458
2022
Q1
$27.9M Hold
5,222,250
0.06% 367
2021
Q4
$39M Hold
5,222,250
0.07% 322
2021
Q3
$47.4M Buy
5,222,250
+3,607,250
+223% +$32.8M 0.09% 278
2021
Q2
$7.88M Hold
1,615,000
0.01% 721
2021
Q1
$7.19M Hold
1,615,000
0.01% 754
2020
Q4
$6.27M Hold
1,615,000
0.01% 748
2020
Q3
$5.22M Hold
1,615,000
0.01% 718
2020
Q2
$7.17M Hold
1,615,000
0.02% 618
2020
Q1
$4.52M Buy
1,615,000
+1,019,928
+171% +$2.86M 0.01% 653
2019
Q4
$2.48M Buy
595,072
+45,072
+8% +$188K 0.01% 958
2019
Q3
$1.93M Buy
550,000
+21,877
+4% +$76.6K ﹤0.01% 1043
2019
Q2
$2.71M Buy
+528,123
New +$2.71M 0.01% 963
2018
Q1
Sell
-14
Closed -$1K 2242
2017
Q4
$1K Sell
14
-6
-30% -$429 ﹤0.01% 2133
2017
Q3
$1K Sell
20
-3
-13% -$150 ﹤0.01% 2101
2017
Q2
$1K Hold
23
﹤0.01% 2095
2017
Q1
$1K Sell
23
-30
-57% -$1.3K ﹤0.01% 2088
2016
Q4
$2K Sell
53
-39,897
-100% -$1.51M ﹤0.01% 2017
2016
Q3
$1.78M Buy
39,950
+13,554
+51% +$604K 0.01% 899
2016
Q2
$1.03M Buy
26,396
+24,482
+1,279% +$953K ﹤0.01% 1089
2016
Q1
$106K Sell
1,914
-9,607
-83% -$532K ﹤0.01% 1559
2015
Q4
$1.59M Hold
11,521
0.01% 965
2015
Q3
$1.66M Hold
11,521
0.01% 933
2015
Q2
$2.99M Buy
+11,521
New +$2.99M 0.01% 770